Abstract
Urinary hydroxyproline concentrations were measured in 36 prostatic cancer patients. Metastases were ruled out by radiography in 24, and confirmed in 12 cases. 14 patients with no malignant disease served as controls. In patients with no metastases excretion was similar to that in the controls, in some of them it was higher. In the patients with higher values the studies were repeated six months later: deposits were found in all cases but one. In the group in which deposits had been present at the outset the values of the untreated patients were significantly higher than in the controls, whereas in the treated patients no consistent values were found.
Similar content being viewed by others
References
Basu, T. K., Donasocon, D., Williams, D.: Urinary hydroxyproline and plasma mucoprotein as an indication of the presence of bone metastasis.Oncology, 30, 197 (1974).
Basu, T. K., Raven, R. W., Dickerson, J. W. T., Williams, D. C.: Leucocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast cancer with skeletal metastases.Eur. J. Cancer, 10, 507 (1974).
Bishop, M. C., Fellows, G. J.: Urine hydroxyproline excretion — a marker of bone metastases in prostatic cancer.Brit. J. Urol., 49, 711 (1977).
Cuschieri, C. S. B.: Urinary hydroxyproline excretion in early and advanced breast cancer — a sequential study.Brit. J. Surg., 60, 800 (1973).
Galasko, C. B. S.: Problems associated with the detection of skeletal metastases.J. Roy. Soc. Med., 71, 38 (1978).
Kolár, J., Vyhnánek, L., Bek, V., Babicky, A., Janko, L., Drápálovau, D.: Zur Diagnostik der Knochenmetastasen bei urologischen Krebskrankheiten mit radioaktiven Isotopen.Zschr. Urol., 8, 578 (1967).
Kontturi, M. J., Sotaniemi, E. A., Larmi, T. K. I.: Hydroxyproline in the early diagnosis of bone metastases in prostatic cancer.Scand. J. Urol., 8, 91 (1974).
Laitinen, O., Nikkilä, E. A., Kivirikko, K. I.: Hydroxyproline in the serum and urine.Acta med. scand., 179, 275 (1966).
Neumann, R. E., Logan, M.: The determination of hydroxyproline.J. B. C., 184, 299 (1950).
Platt, W. D., Doolittle, L. H., Hartschorn, J. W. S.: Urine hydroxyproline excretion in metastatic cancer of the bone.New Engl. J. Med., 271, 267 (1964).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Romics, I., Budavári, I., Kisbenedek, L. et al. Study of hydroxyproline excretion in patients with prostatic cancer. International Urology and Nephrology 13, 275–278 (1981). https://doi.org/10.1007/BF02082425
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02082425